SCHEMBL7305960

SCHEMBL7305960

COC(=O)C(C)c1c(O)nc(C)c2cc(OC)c(OC)cc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.38
PDE3B Q13370 2/20 0.38
PDE3A Q14432 2/20 0.38
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
RAC1 P63000 2/20 0.36
GAA P10253 2/20 0.36
POLB P06746 1/20 0.36
MT-CO2 P00403 1/20 0.36
ALDH1A1 P00352 5/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
GABRA1 P14867 2/20 0.33
GABRA5 P31644 2/20 0.33
GABRA3 P34903 2/20 0.33
GABRA2 P47869 2/20 0.33
GABRA6 Q16445 2/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
MAPT P10636 2/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7317441 0.87 KDM4E (0.39) KDM4EPDE3BPDE3AMEN1KMT2A
SCHEMBL7307941 0.86 PDE3B (0.35) KDM4EPDE3BPDE3AGAAMT-CO2
SCHEMBL7315403 0.83 SLC10A2 (0.37) KDM4EMEN1KMT2AGAAPOLB
SCHEMBL7312102 0.82 PDE3B (0.46) KDM4EPDE3BPDE3AMEN1KMT2A
SCHEMBL9832514 0.74 KDM4E (0.42) KDM4EMEN1KMT2ARAC1GAA
SCHEMBL7447294 0.74 KDM4E (0.42) KDM4EPDE3BPDE3AMEN1KMT2A
SCHEMBL6313239 0.72 KDM4E (0.49) KDM4EPDE3BPDE3AMEN1KMT2A
SCHEMBL12325390 0.72 CYP3A4 (0.46) KDM4EPDE3BPDE3AMEN1KMT2A
Hydrochloric Acid SCHEMBL27947697 0.72 KDM4E (0.46) KDM4EPDE3BPDE3AMEN1KMT2A
SCHEMBL7445322 0.71 ALDH1A1 (0.47) KDM4EMEN1KMT2ARAC1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4822800-A Isoquinolinol compounds having cardiotonic and phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties ORTHO PHARMACEUTICAL CORPORATION (US) 1989-04-18 US disclosed